Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Anticancer Research|April 9, 2005
FOLFOX versus FOLFIRI: a comparison of regimens in the treatment of colorectal cancer metastasesLara Maria Pasetto, Antonio Jirillo, Girolama Iadicicco, et al.Anticancer Research|July 18, 2008
Rectal cancer adjuvant chemotherapy: when is more useful?Lara Maria Pasetto, Umberto Basso, Giulietta Sinigaglia, et al.Pharmacogenetics and Genomics|October 19, 2006
A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiationSalvatore Terrazzino, Marco Agostini, Salvatore Pucciarelli, et al.Cancer|September 17, 2004
Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II studyAlba Ariela Brandes, Alicia Tosoni, Francesca Vastola, et al.Anticancer Research|May 1, 2007
Primary rectal carcinoma in patients with stage IV resectable disease at diagnosisLara Maria Pasetto, Maria Luisa Friso, Salvatore Pucciarelli, et al.Drugs & Aging|August 31, 2007
Determining therapeutic approaches in the elderly with rectal cancerLara Maria Pasetto, Umberto Basso, Maria Luisa Friso, et al.Annals of Surgical Oncology|May 7, 2008
Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgerySalvatore Pucciarelli, Paola Del Bianco, Paola Toppan, et al.Anticancer Research|February 6, 2009
Role of neoadjuvant treatment in cT3N0M0 rectal cancerLara Maria Pasetto, Maria Luisa Friso, Salvatore Pucciarelli, et al.Anticancer Research|February 6, 2009
Neoadjuvant chemoradiotherapy with 5-fluorouracil by bolusLara Maria Pasetto, Giulietta Sinigaglia, Umberto Basso, et al.Anticancer Research|November 11, 2006
Rectal cancer neoadjuvant treatment in elderly patientsLara Maria Pasetto, Maria Luisa Friso, Salvatore Pucciarelli, et al.Pageof 4